Prognostic Factors and Treatment Efficacy in Spinal Cord Sarcoidosis: An Observational Cohort With Long-term Follow-up.
Antoine GavoilleAnne-Claire DesboisBastien JoubertCécile-Audrey DurelClément AuvensEmilie BerthouxThierry DelboyJean François DufourAlin TurcuBernard BonnotteThibault MoreauGuillaume Le GuennoMarc AndréMarc RuivardJean-Philippe CamdessancheJean-Christophe G AntoineRomain MarignierCatherine Chapelon-AbricDavid SaadounPascal SèvePublished in: Neurology (2022)
This study provides Class IV evidence that in individuals with spinal cord neurosarcoidosis, TNF-α antagonists were associated with decreased relapse or progression rate compared to corticosteroids alone, but other therapies showed no significant benefit.